US Patent Issued to Regeneron Pharmaceuticals, Sanofi Biotechnology on Aug. 18 for "Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist" (New York, New Jersey, Connecticut, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,666, issued on Aug. 18, was assigned to Regeneron Pharmaceuticals Inc and Sanofi Biotechnology (Paris).

"Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist" was invented by Jennifer D. Hamilton (Ridgefield, Conn.), Meagan P. O'Brien (New York), Allen Radin (New York), Marcella Ruddy (Wellesley, Mass.) and Heribert Staudinger (Green Brook, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for enhancing the efficacy, safety, and/or tolerability of a grass allergen-specific subcutaneous immunotherapy (SCIT) regimen in a subject having a grass allergy are provided. Methods comprising...